Sign in|Subscribe

ImaiAI News for Operators

Breaking

Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·

Tagged

Rare Disease Diagnosis

AI in Healthcare: How Boston Children’s Hospital Uses OpenAI to Diagnose Rare Diseases

AI in Healthcare: How Boston Children’s Hospital Uses OpenAI to Diagnose Rare Diseases

Boston Children’s Hospital is leveraging OpenAI’s technology to transform pediatric medicine, successfully aiding in the diagnosis of over 40 rare diseases and significantly reducing operational friction for healthcare providers.